|
Originally published In Press as doi:10.1074/jbc.M102613200 on June 18, 2001
J. Biol. Chem., Vol. 276, Issue 34, 31667-31673, August 24, 2001
Regulation of L-type Calcium Channels in Pituitary
GH4C1 Cells by Depolarization*
Ravikumar
Peri ,
David J.
Triggle§, and
Satpal
Singh¶
From the Department of Pharmacology and Toxicology, State
University of New York at Buffalo, Buffalo, New York 14214-3000
Received for publication, March 22, 2001, and in revised form, June 14, 2001
 |
ABSTRACT |
The neurosecretory anterior pituitary
GH4C1 cells exhibit the high
voltage-activated dihydropyridine-sensitive L-type and the low
voltage-activated T-type calcium currents. The activity of L-type
calcium channels is tightly coupled to secretion of prolactin and other
hormones in these cells. Depolarization induced by elevated
extracellular K+ reduces the dihydropyridine
(+)-[3H]PN200-110 binding site density and
45Ca2+ uptake in these cells (22). This study
presents a functional analysis by electrophysiological techniques of
short term regulation of L-type Ca2+ channels in
GH4C1 cells by membrane depolarization.
Depolarization of GH4C1 cells by 50 mM K+ rapidly reduced the barium currents
through L-type calcium channels by ~70% and shifted the voltage
dependence of activation by 10 mV to more depolarized potentials.
Down-regulation depended on the strength of the depolarizing stimuli
and was reversible. The currents recovered to near control levels on
repolarization. Down-regulation of the calcium channel currents was
calcium-dependent but may not have been due to excessive
accumulation of intracellular calcium. Membrane depolarization by
voltage clamping and by veratridine also produced a down-regulation of
calcium channel currents. The down-regulation of the currents had an
autocrine component. This study reveals a calcium-dependent
down-regulation of the L-type calcium channel currents by depolarization.
 |
INTRODUCTION |
Voltage-gated Ca2+ channels control the flux of
Ca2+ across the plasma membrane in a wide range of tissues
and play a crucial role in many physiologic functions that include
excitation-contraction and excitation-secretion coupling. Several major
types of voltage-gated Ca2+ channels have been identified
that differ in their pharmacological and biophysical properties (1-4).
A revised classification scheme based on sequence, biophysical, and
pharmacological properties has been proposed (5). L-type channels,
which are sensitive to 1,4-dihydropyridine antagonists and activators,
are distributed widely in the cardiovascular, central nervous, and
neuroendocrine systems, and the Ca2+ channel antagonists
active at these channels are cardiovascular drugs of clinical
significance (6).
These channels represent an important category of pharmacological
receptors with discrete drug binding sites. The binding sites have been
characterized, and their localization on the major 1
subunit has been well established (7, 8). They are regulated by homologous and heterologous influences and are altered in their expression and function in numerous clinical and pathophysiological conditions (9-13). Activity-dependent regulation is a
common regulatory mechanism in a variety of receptor systems including
ion channels, and electrical activity plays an important role in the
regulation of ion channels. Thus, in many receptors of the G protein
category, persistent activation by agonist ligands causes
down-regulation of the receptor through a process of receptor
internalization that involves an initial reversible phase in which the
receptor can be recycled back to the plasma membrane and a later
irreversible phase in which the receptor is degraded through the
lysosomal machinery (14). In a number of systems, the membrane
potential as an activating signal regulates both the function and
numbers of ion channels. The membrane potential exerts two distinct
categories of control over voltage-gated ion channels including
Ca2+ channels, both of which have the property of shutting
down cellular Ca2+ influx that in excess is a pathological
signal. Inactivation is a rapid event with a time scale of
milliseconds, and down-regulation is a slower event with a time frame
of seconds to minutes or hours. Inactivation has both voltage- and
Ca2+-dependent mechanisms, and recovery is
typically both rapid and complete after the removal of the depolarizing
stimulus (15, 16).
Voltage-gated Ca2+ channels are also subject to a slower
and more persistent regulation by depolarizing stimuli. Thus, in
PC-12 cells (17, 18) and chick retinal neurons (19) that contain L-type Ca2+ channels, chronic depolarization with elevated
extracellular K+ down-regulates the channel density
measured by 1,4-dihydropyridine binding and channel function measured
by 45Ca2+ uptake measurement. In rat myenteric
neurons, persistent depolarization causes a slowly developing long term
reduction in sustained 1,4-dihydropyridine-sensitive calcium channel
current (20). Membrane depolarization reduces both low and high
voltage-activated Ca2+ currents in molluscan neurons (21).
In the neuroendocrine GH4C1 cells, short term
depolarization (up to 2 h) with elevated K+ produces a
decrease in L-type Ca2+ channel density measured by
1,4-dihydropyridine binding and a corresponding decrease in channel
function as measured by 45Ca2+ uptake into
these cells. This decrease in the binding site density is ac-companied
with an increase in affinity for the ligand as anticipated from
voltage-dependent binding (22).
This work was designed to extend our previous study by characterizing
electrophysiologically the short term regulation of L-type
Ca2+ channels in GH4C1 cells by
membrane depolarization. This cell line has a high density and a
relatively pure population of Ca2+ channels of the T- and
L-types (23-26), and the L-type channels are sensitive to
1,4-dihydropyridines (27). Cells of pituitary gland origin are
chemically and electrically excitable, and the activation of L-type
Ca2+ channels is involved in the regulation of persistent
secretion induced by depolarization and hormones such as
thyrotropin-releasing hormone (28-31). The activity and regulation of
Ca2+ channels is physiologically important for maintaining
a homeostasis of hormone secretion. Ca2+ influx into the
cell subsequent to depolarization or hormonal response not only acts as
a trigger for hormone release but also acts to inactivate the channels
and prevent their sustained activation. This is analogous to the
hormone-induced desensitization of receptors (32).
 |
EXPERIMENTAL PROCEDURES |
Materials
Cell Culture Medium
F-10 medium and fetal bovine serum were purchased from Sigma.
Horse serum was purchased from either Sigma or Life Technologies, Inc.
Chemicals
ATP was purchased from Sigma.
BAPTA-AM1 was purchased from
Molecular Probes, Inc. (Eugene, OR).
Glass Electrodes
Electrodes were pulled from thin-walled borosilicate glass
capillaries with an outer diameter of 1.2 mm (TW-120, World
Precision Instruments, Sarasota, FL). The pipettes were pulled in two
stages on a vertical electrode puller (Model 750, David Kopf
Instruments, Tujunga, CA) and had a resistance of 8-10 megohms
when filled with internal recording solution.
Methods
Cell Culture
The rat anterior pituitary cell line,
GH4C1, was obtained from Dr. Jane Chisholm
(Bayer, Inc., West Haven, CT). Cells were maintained in a
monolayer culture in Ham's F-10 medium supplemented with 15%
horse serum and 2.5% fetal bovine serum at 37 °C in a humidified
incubator under an atmosphere containing 5% CO2. Cells were removed from flasks once a week with 0.05% trypsin and were plated either into flasks or sterile 35-mm Petri dishes (Corning) for
electrophysiology experiments. The medium was changed every 2 days.
Cells that were in culture for 2-6 days were used for experiments.
Solutions for Electrophysiology
Normal Tyrode's Solution--
Normal Tyrode's solution
contained 132 mM NaCl, 5.8 mM KCl, 1.2 mM MgCl2·6H2O, 2 mM
CaCl2·2H2O, 10 mM HEPES, and 5 mM dextrose. The pH was adjusted to 7.4 with NaOH.
Depolarizing Tyrode's Solution--
Depolarizing Tyrode's
solution contained 87 mM NaCl, 50 mM KCl, 1.2 mM MgCl2·6H2O, 2 mM
CaCl2·2H2O, 10 mM HEPES, and 5 mM dextrose. The pH was adjusted to 7.4 with NaOH.
External Recording Solution--
External recording solution
contained 125 mM
N-methyl-D-glucamine, 5 mM
CsCl, 10 mM HEPES, 1 mM
MgCl2·6H2O, 5 mM dextrose, and 20 mM BaCl2. 105 ml of 1 N
HCl/liter of solution was added. The pH was adjusted to 7.4 with CsOH.
Internal Recording Solution--
Internal recording solution
contained 60 mM CsCl, 1 mM
CaCl2·2H2O, 1 mM
MgCl2·6H2O, 10 mM HEPES, 11 mM EGTA, 50 mM aspartic acid, and 5 mM Na2ATP. The pH was adjusted to 7.4 with CsOH.
Electrophysiology
Whole cell voltage clamp experiments were carried out using an
Axopatch 200 amplifier (Axon Instruments, Inc. Foster City, CA).
Voltage commands were generated on a MacIntosh IIci computer through a
12-bit digital to analog converter using a MacADIOS II/16 board (GW
Instruments, Somerville, MA). Data were acquired after 16-bit analog to
digital conversion. Further analysis was performed with a program
written in the laboratory by Dr. Satpal Singh in Think-C (Symantec
Corporation, Cupertino, CA). Test currents were digitally sampled
every 500 µs, except during the examination of capacitative currents,
which were sampled every 100 µs. Currents were digitally corrected
for linear leakage with respect to currents obtained at 60 mV from a
holding potential of 40 mV. Current densities expressed as pA/pF were
calculated by dividing the measured current with the cell capacitance
to avoid the differences in current amplitude that arise because of the
differences in cell size. Currents were filtered at 5 kHz with a
Lowpass Bessel filter.
All voltage clamp traces represent an average data from several
different cells. To generate the current voltage profiles (I-V plots),
current amplitudes at the peak current value were measured for each
voltage command. All data are shown as mean values ± S.E.
Cells were rinsed with 1 ml of 5.8 mM K+ buffer
and incubated for the desired time interval in the appropriate buffer
at 37 °C. At the end of the incubation, whole cell barium currents
were elicited by step depolarizations to different potentials from a
holding potential of 40 mV. T-type channels present in these cells
inactivate by holding at 40 mV, and the L-type channels can then be
studied selectively (27). The current recorded under these experimental
conditions is inhibited by 1,4-dihydropyridines, which are specific
L-type calcium channel blockers, in our experiments (33) done in
parallel to the experiments reported here as well as in recordings made
by several other groups (e.g. see Refs. 23-25, 27).
Cells were continuously bathed in the appropriate Tyrode's solution
until the whole cell configuration was achieved. Recording solution was
locally applied to the cells by a gravity-driven perfusion system.
Whole cell barium currents were recorded from a single cell in the
dish. To avoid interference from a rundown of currents, the recordings
were completed within 3-5 min of establishing the whole cell
configuration unless otherwise specified. For clarity, only the
currents to +10 mV have been shown in all the current traces.
Capacitative currents settled rapidly within 2 ms in these cells.
Hence, the first and the last 3 ms have been removed from the current
traces to avoid interference from capacitative currents.
 |
RESULTS |
Current Characteristics--
GH4C1 cells
express L-type calcium channels. The currents through these channels
have been previously characterized both by whole cell and single
channel experiments. To establish a base line for studying the calcium
channel regulation, the cells were bathed in resting Tyrode's solution
(5.8 mM K+) for up to 2 h at
37 °C after removing the culture medium. Barium currents were
measured from the cells at the end of the incubation. The total barium
current density measured after preincubation in Tyrode's solution at
37 °C remained within 85-90% of the amplitude of the current
observed without any preincubation. The current traces at +10 mV after
different incubation times are shown in Fig.
1A, and the current-voltage
relationship is shown in Fig. 1B. A plot of normalized
currents elicited by step depolarization to +10 mV from a holding
potential of 40 mV at different incubation times is shown in Fig.
1C. This shows that the preincubation of GH4C1 cells in serum-free buffer at 37 °C
over 2-h time periods does not alter the stability of L-type calcium
channel currents. However, once the whole cell configuration was
established, the current rapidly ran down to smaller levels within 10 min. All recordings were therefore completed within 3-5 min after
establishing the whole cell configuration at the end of any
preincubation. The average L-type calcium channel current density
obtained using 20 mM barium as an external charge carrier
was 17-19 pA/pF. Cell capacitance measured during the experiment using
a hyperpolarizing pulse to 60 mV from a holding potential of 40 mV
was ~21-23 pF.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
GH4C1
cells express stable L-type calcium channel currents. Cells
were incubated in 5.8 mM K+-Tyrode for
different time intervals at 37 °C. At the end of the incubation,
whole cell currents were measured by depolarizing step pulses from a
holding potential of 40mV. Data represent averages of 7-9 cells.
A, current traces at 60 mV and +10 mV subsequent to
different times of incubation (in min) above the current traces in 5.8 mM K+-Tyrode at 37 °C. B, current
voltage profiles (symbols as shown in A).
C, peak current at +10 mV as a function of time of
incubation.
|
|
Effects of Cellular Depolarization on Currents--
Cellular
depolarization by preincubating the cells in depolarizing Tyrode's
solution (50 mM K+) rapidly down-regulated the
currents. The current density decreased from 17.39 ± 0.82 pA/pF
to 5.36 ± 0.35 pA/pF within 5 min of depolarization, indicating a
69% decrease in the current amplitude (Fig.
2A). The time course of
down-regulation was established by preincubating cells in depolarizing
Tyrode's solution (50 mM K+) for different
time periods. Down-regulation reached a maximal level within 5 min, and
longer durations of preincubations up to 1 h did not further
increase the extent of down-regulation (Fig. 2, A and
B). Depolarization-induced (50 mM
K+) down-regulation was reversible. After 30 min of
down-regulation by preincubating the cells in depolarizing 50 mM K+-Tyrode's solution, the cells were
allowed to recover in resting Tyrode's solution for different time
periods (Fig. 2C). Currents elicited by pulses to +10 mV are
shown to depict the recovery from down-regulation. The currents
recovered to 80-85% of control levels within 30-45 min of
repolarization (Fig. 2D). This also suggests that the
phenomenon observed is down-regulation and not the calcium and
voltage-dependent inactivation of calcium channels as the
recovery from inactivation is relatively fast and complete within
seconds.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
L-type calcium channels in
GH4C1 cells are down-regulated by
depolarization. Cells were incubated either in 5.8 mM
K+ buffer for 30 min or in 50 mM K+
buffer for different time intervals at 37 °C. At the end of
incubation, the whole cell currents were measured. Data represent
averages of 7-9 cells. A, current traces at 60 mV and +10
mV. B, current voltage profiles (symbols as shown
in A). Down-regulation of currents on depolarization was a
reversible phenomenon, and the currents reverted close to control
levels on repolarization. Cells were depolarized in 50 mM
K+ buffer for 30 min and reverted to resting 5.8 mM K+ buffer for different time intervals. At
the end of incubation, the whole cell currents were measured.
C, current traces at 60 mV and +10 mV in resting
condition, depolarized condition, and during recovery. D,
recovery from down-regulation is plotted as a function of
repolarization time.
|
|
Down-regulation of L-type calcium channel currents depended on
the extent of depolarization. Increasing the concentration of
K+ ions in the external buffer increased the depolarization
stimulus and the extent of down-regulation. The resting cell potential measured in 5.8 mM K+-Tyrode was 65 to 70
mV and changed to approximately 15 mV in 50 mM
K+-Tyrode. The current density decreased with the
increase in levels of extracellular potassium in the depolarizing
buffer (Fig. 3, A and
B). Down-regulation reached a maximum at 50 mM
extracellular [K+], beyond which any further increase of
[K+] did not produce a further decrease in the currents
(Fig. 3C).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 3.
Down-regulation depends on the
strength of the depolarizing stimulus. Cells were incubated in
buffers containing different concentrations of K+ for 30 min at 37 °C. At the end of incubation, the whole cell currents were
measured. Data represent averages of 6-8 cells. A,
current traces at 60 mV and +10 mV after incubation in different
concentrations of K+. B, current voltage
profiles (symbols representing in mM the
concentration of potassium ions in extracellular buffer are shown in
A). C, percent down-regulation of current at +10
mV as a function of extracellular [K+]. Voltage clamping
the cell at 10 mV also down-regulated L-type calcium channel
currents. Cells were bathed in 5 mM K+ buffer,
and the whole cell barium currents recorded from a holding potential of
40 mV. The same cell was then held at 10 mV for 5 min, and then the
barium current was recorded from a holding potential of 40 mV. Data
represent averages of 6-8 cells. D, current traces at 60
mV and +10 mV. E, current voltage profiles (filled
circles represent control, and open circles represent
traces after holding the cell at 10 mV for 5 min).
|
|
To investigate whether the down-regulation was because of cellular
depolarization and not nonspecifically because of excessive potassium
in the external depolarizing buffer, we explored alternate depolarization mechanisms. 50 mM K+ depolarizes
the cell to approximately 15 mV. A similar change in membrane
potential can be introduced in cells in resting Tyrode's buffer
by voltage clamping them. If depolarization were to produce a
down-regulation, this should produce a similar decrease in the current
amplitude. We examined this hypothesis in an experiment where we
measured the whole cell currents from a holding potential of 40
mV before and after voltage clamping the cell at 10 mV for 5 min in
5.8 mM K+- Tyrode's solution. Voltage clamping
at 10 mV for 5 min decreased the current amplitude in a manner
similar to the down-regulation observed with 50 mM
K+ treatment (Fig. 3, D and E).
Another mode of depolarization also produced a down-regulation of
L-type currents. Cells were exposed to the alkaloid veratridine, a
sodium channel activator, for 30 min (34, 35). Veratridine decreased
the calcium channel currents in a concentration-dependent manner (concentration response data not shown). Treatment with 50 µM veratridine for 30 min decreased the current density
by 22%. The current density decreased from 15.87 ± 0.61 pA/pF to 12.34 ± 1.06 pA/pF (Fig. 4,
A and B). The decrease in the current density was
also accompanied with an enhanced inactivation of the current. Thus,
the different modes of depolarization had different effects on
down-regulation. Normalized current-voltage curves for cells
depolarized with 50 mM K+ or with veratridine
are shown in Fig. 4, C and D. Cells depolarized with elevated extracellular [K+] shifted the peak current
to +20 mV from +10 mV, but cells depolarized with veratridine did not
show any voltage shift in peak current. Over the 200-ms pulse duration,
cells depolarized with elevated extracellular [K+] did
not show any kinetic changes, but cells depolarized with veratridine
showed a faster inactivation of currents (Fig. 4A).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 4.
Comparison of down-regulation induced by 50 mM K+ and 50 µM veratridine. Comparison of the
effect of depolarization produced by veratridine and by 50 mM K+. Cells were incubated either in 5.8 mM K+ buffer in the presence and absence of 50 µM veratridine or in 50 mM K+
buffer at 37 °C for 30 min. At the end of incubation, the whole cell
currents were measured. Depolarization by 50 mM
K+ did not affect the channel inactivation over 200 ms, but
depolarization with veratridine enhanced the inactivation. Data
represent averages of 6-8 cells. A, current traces at 60
mV and +10 mV. B, current voltage profiles
(symbols as shown in A). C, comparison
of normalized I-V plots from cells without 50 µM
veratridine (filled circles) and with 50 µM
veratridine (open circles) treatment. D,
comparison of normalized I-V plots from 5.8 mM
K+-treated (filled circles) and 50 mM K+-treated (open circles) cells.
Depolarization by 50 mM K+ shifted the voltage
dependence of activation by +10 mV, but depolarization by veratridine
did not induce a shift in the voltage dependence of activation. Data
represent averages of 6-8 cells.
|
|
Ca2+ Dependence of K+
Depolarization-induced Down-regulation--
The presence of
[Ca2+] in the extracellular depolarizing buffer was
essential for the down-regulation of currents. The removal of
[Ca2+] from depolarizing buffer to the contaminating
levels in double distilled water inhibited the down-regulation, and the
current density remained the same as in the cells incubated in normal Tyrode's buffer. The current traces at +10 mV and the current-voltage relationships in depolarizing buffers having different Ca2+
concentrations are shown in Fig. 5,
A and B. The down-regulation was enhanced with an
increasing concentration of Ca2+ in the depolarizing 50 mM K+ buffer (Fig. 5C).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
Down-regulation of L-type calcium channels
requires the presence of Ca2+ in extracellular buffer.
The effect of extracellular Ca2+ on depolarization-induced
down-regulation of currents is shown. Cells were incubated in 50 mM K+ buffers containing different
concentrations of Ca2+ for 30 min at 37 °C. At the end
of incubation, the whole cell currents were measured. Data represent
averages of 6-8 cells. A, current traces at 60 mV and +10
mV. B, current voltage profiles (symbols as shown
in A). C, Percent inhibition of current at +10 mV
as a function of extracellular [Ca2+]. Preloading the
cells with BAPTA-AM did not prevent the down-regulation produced with
50 mM K+. Cells were incubated in 5.8 mM K+-Tyrode containing 25 µM
BAPTA-AM for 30 min at 37 °C and then switched to either 5.8 mM K+ or 50 mM
K+-Tyrode containing 25 µM BAPTA-AM for
another 30 min at 37 °C. At the end of incubation, the whole cell
currents were measured. Data represent averages of 8-10 cells.
D, current traces at 60 mV and +10 mV. E,
current voltage profiles (filled circles, 5.8 mM
K+ and open circles, 50 mM
K+ in the presence of 25 µM BAPTA-AM).
|
|
BAPTA-AM, a cell permeant analog of BAPTA, chelates intracellular
calcium after the hydrolysis of the acetomethoxy-functional group (AM)
inside the cell. Preloading the cells with 25 µM BAPTA-AM before depolarization did not inhibit the down-regulation caused by
depolarization (Fig. 5, D and E). This suggests
that the down-regulation may not be attributed to the accumulation of
excess Ca2+ inside the cell. It might also be because of
the fact that the molecular determinants of the Ca2+
channel responsible for the down-regulation may be located in microdomains inaccessible to BAPTA-AM.
Autocrine Component of Down-regulation--
Depolarization-induced
down-regulation appeared to have an autocrine component. When the cells
were bathed in a stream of depolarizing 50 mM
K+ buffer as opposed to stagnant buffer, a part of the
down-regulation was relieved (Fig. 6).
This suggests that hormones or other factors that are released by these
anterior pituitary cells into the surrounding medium on depolarization
may act on the channels and inhibit their activity. This could be
prevented in the stream of depolarizing buffer if the factors are
washed out from the vicinity of the cells. However, a substantial
component of down-regulation still persisted that was independent of
the factors released from the cell, suggesting alternate mechanisms for
the down-regulation of the remaining component of the L-type
current.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 6.
Autocrine component of down-regulation.
GH4C1 cells were depolarized either in stagnant
50 mM K+ buffer for 5 min or in a continuous
stream of 50 mM K+ for 5 min. At the end of
this brief exposure to depolarizing buffer, the whole cell currents
were measured. Data represent averages of 6-8 cells. A,
current traces at 60 mV and +10 mV. B, current voltage
profiles (symbols as shown in A).
|
|
 |
DISCUSSION |
Membrane potential is an important regulator of ion channel
activity. Whereas cellular depolarization on one hand is an important physiologic signal, it also serves as a pathophysiologic trigger. Membrane depolarization can bring about both up- and down-regulation of
the channel activity. In PC-12 cells, prolonged depolarization by elevated extracellular K+ causes concomitant time- and
concentration-dependent decreases in both
[3H]nitrendipine binding and
depolarization-dependent uptake of 45Ca2+, indicating a decrease in the channel
number and function (18). In chick neural retinal cells, chronic
depolarization reduces (+)-[3H]PN200-110 binding and
45Ca2+ uptake (19). Chronic depolarization
decreases the density of the macroscopic Ca2+ currents in
the rat myenteric neurons (36). In pituitary
GH4C1 cells, short term depolarization for
periods of up to 2 h decreases the (+)-[3H]PN200-110
binding site density by 10-fold accompanied by a 20-fold increase in
drug affinity (22). In all of these studies the regulation depended on
the presence of extracellular calcium. Cellular depolarization can also
cause an up-regulation of the surface channels as well. Depolarization
of chick myotubes has been shown to trigger the appearance of
(+)-[3H]PN200-110 binding sites (37). Binding studies
with the radioligand 125I- -CgTx on subcellular fractions
show that the intracellular pool of neuronal N-type Ca2+
channels in PC-12-251 cells and IMR-32 cells constituted
60-80% of the total calcium channels (38, 39). This intracellular pool of channels is recruited to the cell membrane on depolarization with KCl. The cell surface 125I- -CgTx binding sites
increased by >200% within 10 min of depolarization with 55 mM KCl. This transiently decreased over a period of 1 h and then stabilized at a level that was higher than the control level.
In this study, we show an electrophysiologic correlation of the calcium
channel regulation in pituitary GH4C1 cells by
short term membrane depolarization. GH4C1 and
GH3 pituitary clonal cells express L-type calcium channels.
Currents through these channels have been characterized both by whole
cell and single channel experiments (23-25, 40, 41). Short term
regulation studies using radioligand binding were also done on these
cells (22). Hence, we chose these cells as a model system to study the
functional aspects of calcium channel regulation electrophysiologically.
We show that cellular depolarization with elevated extracellular
potassium produced an ~70% decrease in the barium current density in
GH4C1 cells. This process is very rapid, and
the decrease in currents is evident with depolarizations as short as 5 min. Even though the earlier studies involving
(+)-[3H]PN200-110 binding have evaluated the regulation
of the channel activity for periods shorter than half an hour, these
studies may not be accurate because of the limitation posed by
equilibration of the ligand with receptor. In addition and unlike the
(+)-[3H]PN200-110 binding experiments, the
electrophysiologic experiments evaluate the channel activity in the
absence of any exogenous 1,4-dihydropyridines, thus precluding any
possible additional regulation of the channel by the antagonist itself.
Our study also shows that the down-regulation of the L-type calcium
channels by depolarization is a reversible phenomenon, and that the
currents recover to near control levels when the cells are placed in
normal 5.8 mM K+-Tyrode. The extent of
down-regulation depended on the depolarizing stimuli and increased as
the membrane potential was raised by increasing the extracellular
potassium. Qualitatively, no appreciable changes in the channel
kinetics were observed between the control cells and the cells
depolarized with 50 mM K+ using barium as
charge carrier. However, the down-regulation was accompanied with a +10
mV shift in the voltage dependence of activation to a more depolarized
potential. Depolarization of cells by voltage clamping at 10 mV also
produced a down-regulation similar to depolarization produced by 50 mM K+. The depolarization of cells with
veratridine, a sodium channel activator, also produced a decrease in
the channel currents. However, this decrease is not as dramatic as seen
with 50 mM K+ and also does not shift the
voltage dependence of activation.
In our experiments, we observed that the down-regulation of the channel
activity could be partially relieved by depolarizing the cells in a
stream of depolarizing 50 mM K+ buffer rather
than in the stagnant buffer. This finding suggests that a factor or
factors may be released by these cells on depolarization with 50 mM K+ to act on the cell in a feedback manner
under the conditions of sustained depolarization and to inhibit the
channel activity. In a stream of the buffer, these factors are removed,
which prevents their feedback activity on the cells.
Hormone-induced modulation of channels is inherent to
neurosecretory cells. The activation of calcium channels is essential
for the release of hormones like prolactin, GH, and
adrenocorticotropic hormone from the anterior pituitary cells
(42, 43). Physiologically, this can be achieved by the action of
hormones like thyrotropin-releasing hormone. Depolarization with
elevated potassium also leads to hormonal release in in
vitro assays. On the other hand, certain hormones like
somatostatin inhibit calcium channel activity and suppress the release
of the pituitary hormones. This autocrine regulation of calcium
channels is thought to be mediated through G proteins-Go in
pituitary cells (29, 42, 44).
The presence of extracellular calcium ions was essential for the
down-regulation, indicating that it is a calcium-dependent process. Elimination of Ca2+ from depolarizing buffer
abolished the down-regulation. Here we show that as the calcium
concentration is increased to physiologic levels in the depolarizing
buffer, the down-regulation is gradually enhanced. However, the
preincubation of cells with 25 µM BAPTA-AM, a cell
permeant calcium chelator before depolarization, failed to relieve the
down-regulation. This suggests two possibilities: (a) even
though BAPTA-AM was hydrolyzed to BAPTA inside the cell, there was a
constant flux of Ca2+ from the extracellular medium,
saturating BAPTA and thereby preventing its action, and (b)
the site of action of Ca2+ on the channel to produce
regulation is very close to the channel pore and is inaccessible to
intracellular chelators.
Calcium- and voltage-dependent inactivation of L-type
calcium channels are well studied phenomena (16, 45-48). In our study, the depolarizing buffer (50 mM K+) contained 2 mM Ca2+ and could induce voltage- and/or
Ca2+-dependent inactivation of the channel.
However, the phenomenon observed in our study is not a
voltage-dependent inactivation, because it does not occur
with depolarization in the absence of Ca2+ in the
depolarizing buffer. In addition, the recovery from both voltage- and
Ca2+-dependent inactivation is relatively fast
and occurs within a few seconds for fast inactivation and within 1-2
min for slow inactivation (47-49). On the other hand, the recovery
from depolarization-induced regulation occurred over a period of 30-45
min in our studies, suggesting that it is down-regulation and not
inactivation. This finding is also consistent with the decrease in the
binding site density observed in response to depolarization in the
earlier experiments (22).
In conclusion, we present evidence for depolarization-induced
down-regulation of currents through L-type calcium channels in
GH4C1 cells. This is a reversible phenomenon.
The down-regulation of L-type calcium channels is
calcium-dependent and requires the presence of external
calcium. The data suggest but do not prove the direct action of calcium
on calcium channel to induce the down-regulation. The possible
mechanisms for down-regulation may involve an autocrine component.
 |
FOOTNOTES |
*
This work was supported in part by grants from Bayer, Inc.,
and Astra-Zeneca Pharmaceuticals, and Grant GM-50779 from the National
Institutes of Health.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: DuPont Pharmaceuticals Company, Experimental
Station, Route 141 and Henry Clay Rd., Wilmington, DE 19880.
§
Present address: School of Pharmacy and Pharmaceutical Sciences,
State University of New York at Buffalo, Buffalo, NY 14260.
¶
To whom correspondence should be addressed: Dept. of
Pharmacology and Toxicology, 102 Farber Hall, State University of New York at Buffalo, Buffalo, NY 14214-3000. Tel.: 716-645-3870; Fax: 716-645-3870; E-mail: singhs@acsu.buffalo.edu.
Published, JBC Papers in Press, June 18, 2001, DOI 10.1074/jbc.M102613200
 |
ABBREVIATIONS |
The abbreviations used are:
BAPTA-AM, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic
acid tetra(acetoxymethyl)ester;
pA/pF, picoamperes/picofarad;
GH, growth hormone.
 |
REFERENCES |
| 1.
|
Bean, B. P.
(1989)
Annu. Rev. Physiol.
51,
367-384
|
| 2.
|
Miller, R. J.
(1987)
Science
235,
46-52
|
| 3.
|
Miller, R. J.
(1992)
J. Biol. Chem.
267,
1403-1406
|
| 4.
|
Tsien, R. W.,
Lipscombe, D.,
Madison, D.,
Bley, K.,
and Fox, A.
(1995)
Trends Neurosci.
18,
52-54
|
| 5.
|
Ertel, E. A.,
Campbell, K. P.,
Harpold, M. M.,
Hofmann, F.,
Mori, Y.,
Perez-Reyes, E.,
Schwartz, A.,
Snutch, T. P.,
Tanabe, T.,
Birnbaumer, L.,
Tsien, R. W.,
and Catterall, W. A.
(1994)
Neuron
13,
505-506
|
| 6.
|
Triggle, D. J.
(1998)
in
Calcium Antagonists in Clinical Medicine
(Epstein, M., ed), 2nd Ed.
, pp. 1-26, Hanley and Belfus, Philadelphia, PA
|
| 7.
|
Hockerman, G. H.,
Peterson, B. Z.,
Johnson, B. D.,
and Catterall, W. A.
(1997)
Annu. Rev. Pharmacol. Toxicol.
37,
361-396
|
| 8.
|
Striessnig, J.,
Grabner, M.,
Mitterdorfer, J.,
Hering, S.,
Sinnegger, M. J.,
and Glossmann, H.
(1998)
Trends Pharmacol. Sci.
19,
108-115
|
| 9.
|
Ferrante, J.,
and Triggle, D. J.
(1990)
Pharmacol. Rev.
42,
29-44
|
| 10.
|
Ferrante, J.,
and Triggle, D. J.
(1990)
Biochem. Pharmacol.
39,
1267-1270
|
| 11.
|
Greenberg, D. A.
(1999)
Muscle Nerve
22,
1341-1349
|
| 12.
|
Mukherjee, R.,
and Spinale, F. G.
(1998)
J. Mol. Cell. Cardiol.
30,
1899-1916
|
| 13.
|
Ophoff, R. A.,
Terwindt, G. M.,
Ferrari, M. D.,
and Frants, R. R.
(1998)
Histol. Histopathol.
13,
827-836
|
| 14.
|
Dargent, B.,
Jullien, F.,
and Couraud, F.
(1995)
J. Neurochem.
65,
407-413
|
| 15.
|
Zhang, J. F.,
Ellinor, P. T.,
Aldrich, R. W.,
and Tsien, R. W.
(1994)
Nature
372,
97-100
|
| 16.
|
Imredy, J. P.,
and Yue, D. T.
(1994)
Neuron
12,
1301-1318
|
| 17.
|
DeLorme, E. M.,
and McGee, R.
(1986)
Brain Res.
397,
189-192
|
| 18.
|
DeLorme, E. M.,
Rabe, C. S.,
and McGee, R.
(1988)
J. Pharmacol. Exp. Ther.
244,
838-843
|
| 19.
|
Ferrante, J.,
Triggle, D. J.,
and Rutledge, A.
(1991)
Can. J. Physiol. Pharmacol.
69,
914-920
|
| 20.
|
Franklin, J. L.,
Fickbohm, D. J.,
and Willard, A. L.
(1992)
J. Neurosci.
12,
1726-1735
|
| 21.
|
Berdan, R.,
Easaw, J. C.,
and Wang, R.
(1993)
J. Neurophysiol.
69,
151-164
|
| 22.
|
Liu, J.,
Bangalore, R.,
Rutledge, A.,
and Triggle, D. J.
(1994)
Mol. Pharmacol.
45,
1198-1206
|
| 23.
|
Armstrong, C. M.,
and Matteson, D. R.
(1985)
Science
227,
65-67
|
| 24.
|
Matteson, D. R.,
and Armstrong, C. M.
(1986)
J. Gen. Physiol.
87,
161-182
|
| 25.
|
Dubinsky, J. M.,
and Oxford, G. S.
(1984)
J. Gen. Physiol.
83,
309-339
|
| 26.
|
Simasko, S. M.,
Weiland, G. A.,
and Oswald, R. E.
(1988)
Am. J. Physiol.
254,
E328-E336
|
| 27.
|
Cohen, C. J.,
and McCarthy, R. T.
(1987)
J. Physiol. (Lond.)
387,
195-225
|
| 28.
|
Rosenthal, W.,
Hescheler, J.,
Hinsch, K. D.,
Spicher, K.,
Trautwein, W.,
and Schultz, G.
(1988)
EMBO J.
7,
1627-1633
|
| 29.
|
Rosenthal, W.,
Hescheler, J.,
Trautwein, W.,
and Schultz, G.
(1988)
FASEB J.
2,
2784-2790
|
| 30.
|
Enyeart, J. J.,
Aizawa, T.,
and Hinkle, P. M.
(1985)
Am. J. Physiol.
248,
C510-C519
|
| 31.
|
Tan, K. N.,
and Tashjian, A. H., Jr.
(1984)
J. Biol. Chem.
259,
427-434
|
| 32.
|
Freedman, N. J.,
and Lefkowitz, R. J.
(1996)
Recent Prog. Horm. Res.
51,
319-351
|
| 33.
|
Peri, R.,
Padmanabhan, S.,
Rutledge, A.,
Singh, S,
and Triggle, D. J.
(2000)
J. Med. Chem.
43,
2906-2914
|
| 34.
|
Dargent, B.,
and Couraud, F.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
5907-5911
|
| 35.
|
Dargent, B.,
Arsac, C.,
Tricaud, N.,
and Couraud, F.
(1996)
Neuroscience
73,
209-216
|
| 36.
|
Fitzpatrick, D. B.,
and Karmazyn, M.
(1984)
J. Pharmacol. Exp. Ther.
228,
761-768
|
| 37.
|
Wang, G. K.,
and Wang, S. Y.
(1994)
J. Gen. Physiol.
103,
501-518
|
| 38.
|
Sher, E.,
and Clementi, F.
(1991)
Neuroscience
42,
301-307
|
| 39.
|
Passafaro, M.,
Clementi, F.,
and Sher, E.
(1992)
J. Neurosci.
12,
3372-3379
|
| 40.
|
Hagiwara, S.,
and Ohmori, H.
(1983)
J. Physiol. (Lond.)
336,
649-661
|
| 41.
|
Scherubl, H.,
and Hescheler, J.
(1991)
Proc. R. Soc. Lond. Ser. B Biol. Sci.
245,
127-131
|
| 42.
|
Schultz, G.,
and Hescheler, J.
(1993)
Arzneim.-Forsch.
43,
229-232
|
| 43.
|
Simasko, S. M.
(1991)
Endocrinology
128,
2015-2026
|
| 44.
|
Wickman, K. D.,
and Clapham, D. E.
(1995)
Curr. Opin. Neurobiol.
5,
278-285
|
| 45.
|
Neely, A.,
Olcese, R.,
Wei, X.,
Birnbaumer, L.,
and Stefani, E.
(1994)
Biophys. J.
66,
1895-1903
|
| 46.
|
de Leon, M.,
Wang, Y.,
Jones, L.,
Perez-Reyes, E.,
Wei, X.,
Soong, T. W.,
Snutch, T. P.,
and Yue, D. T.
(1995)
Science
270,
1502-1506
|
| 47.
|
Sokolov, S.,
Weiss, R. G.,
Timin, E. N.,
and Hering, S.
(2000)
J. Physiol. (Lond.)
527,
445-454
|
| 48.
|
Hering, S.,
Berjukow, S.,
Sokolov, S.,
Marksteiner, R.,
Weiss, R. G.,
Kraus, R.,
and Timin, E. N.
(2000)
J. Physiol. (Lond.)
528,
237-249
|
| 49.
|
Zuhlke, R. D.,
Pitt, G. S.,
Deisseroth, K.,
Tsien, R. W.,
and Reuter, H.
(1999)
Nature
399,
159-162
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|